About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  HISTORICAL VOLUME
Historical Volume      
Orchid Pharma Ltd.
BSE Code 524372
ISIN Demat INE191A01027
Book Value 263.83
NSE Code ORCHPHARMA
Dividend Yield % 0.00
Market Cap 31438.24
P/E 74.05
EPS 8.37
Face Value 10  
Exchange : Period From : Period To :
DateOpen Price(Rs.)High Price(Rs.)Low Price(Rs.)Close Price(Rs.)VolumeTurnover
27-Feb-2026 626.65 626.70 617.00 619.85 1862 1156409
26-Feb-2026 629.00 640.25 618.05 629.35 2292 1442012
25-Feb-2026 655.55 655.55 623.00 628.00 4356 2757895
24-Feb-2026 655.30 655.50 642.00 645.85 1623 1054944
23-Feb-2026 667.85 677.80 655.50 665.25 2382 1587922
20-Feb-2026 662.00 671.25 660.85 668.40 498 332833
19-Feb-2026 668.50 677.00 667.10 669.00 175 117419
18-Feb-2026 662.50 674.55 662.50 668.40 685 457690
17-Feb-2026 664.40 670.65 662.50 663.60 591 393949
16-Feb-2026 664.60 666.55 649.00 665.10 2116 1394534
13-Feb-2026 675.00 675.00 651.15 664.50 2169 1433129
12-Feb-2026 670.00 680.90 660.05 675.55 1454 975130
11-Feb-2026 696.50 696.50 684.00 689.10 908 626397
10-Feb-2026 694.30 713.65 681.30 687.80 1647 1143996
09-Feb-2026 684.00 701.95 681.35 694.20 1141 792067
06-Feb-2026 678.05 683.00 676.45 681.25 2083 1417407
05-Feb-2026 699.00 701.35 683.55 688.40 1127 781572
04-Feb-2026 697.50 714.45 695.30 701.25 1058 744816
03-Feb-2026 705.45 705.45 674.30 699.60 3158 2154638
02-Feb-2026 688.00 688.00 654.20 674.20 489 327770
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.